CTLA-4 Checkpoint

Article 6

CTLA-4 CHECKPOINT

The CTLA-4 checkpoint is a global regulator of T-cell activation. CTLA-4 is expressed exclusively on T cells, where it regulates the magnitude of the early stages of T-cell activation.

CTLA-4 primarily counteracts the activity of the T-cell co-stimulatory receptor CD28. When a TCR recognizes antigen-MHC complexes on the surface of antigen-presenting cells, CD28 on the surface of T cells can also bind to CD80 (B7.1) and CD86 (B7.2) on antigen-presenting cells. Co-stimulation of CD28 signaling strongly amplifies the TCR signal to activate T cells.

After T-cell activation, intracellular stores of CTLA-4 migrate to the cell surface. CD28 and CTLA-4 share identical ligands—B7.1 and B7.2. Because CTLA-4 has a much higher overall affinity for both ligands, its expression on the surface of T cells dampens the activation of T cells by outcompeting CD28 in binding B7.1 and B7.2, as well as by actively delivering inhibitory signals to the T cell, both of which result in T-cell inactivation.

Blocking CTLA-4 helps stimulate T-cell activation and proliferation. This supports the critical role of CTLA-4 as an inhibitory regulator of T-cell-dependent immune responses.

Thus, blocking CTLA-4 helps stimulate T-cell activation and proliferation.

For more information, select the animation, which illustrates T-cell inactivation through CTLA-4 signaling.